Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities

Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities ST. LOUIS, April 23, 2018 /PRNewswire/ — Thermo Fisher Scientific announced today that is investing $50 million in its St. Louis, Missouri site which is one of the company’s Centers of Excellence (COE) for Biological Commercial Manufacturing. The investment is part of a deliberate strategy... Read more

Brad Kreger Joins Fluidigm as Senior Vice President, Global Operations

PDF Version SOUTH SAN FRANCISCO, Calif., April 23, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Brad Kreger as Senior Vice President, Global Operations. In this role, Kreger leads global manufacturing, supply chain, demand planning, and distribution for Fluidigm. As a member of the executive leadership team reporting to President and CEO Chris Linthwaite, Kreger will be responsible for... Read more

Neogen names Donofrio VP of Food Safety R&D

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., April 19, 2018 — Neogen Corporation (NASDAQ: NEOG) announced today that it had named Dr. Robert Donofrio as Vice President of Food Safety Research and Development. Donofrio had recently served as the director of this group of 75 scientists. “Neogen’s Board of Directors is pleased to... Read more

MIT Spinout, ReviveMed, Raises $1.5M to Advance its AI-Driven Metabolomic Platform for Drug Discovery

Cambridge, MA – April 18, 2018 ReviveMed Inc., today announced it has closed an oversubscribed seed round of $1.5 million to advance its artificial intelligence (AI)-driven platform that unlocks the value of metabolomics data for drug discovery and development. Rivas Capital led the round, which also included participation from several institutional investors including TechU, Team... Read more

MilliporeSigma Wins INTERPHEX Exhibitor Award for Best Technological Innovation

Award recognizes new, fully synthetic clarification filter Millistak+® HC Pro portfolio of depth filters improves capacity, reducing footprint by up to 2x for primary clarification Burlington, Massachusetts, April 18, 2018 — MilliporeSigma today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation. “MilliporeSigma is dedicated to delivering innovations that bring... Read more

Thermo Fisher Scientific Showcases Bioprocessing Workflow Solutions at INTERPHEX

Integrated products, software and services designed to drive bioprocessing productivity NEW YORK, April 17, 2018 /PRNewswire/ — INTERPHEX 2018 — Thermo Fisher Scientific, the world leader in serving science, today announced the bioprocessing technologies to be featured at their International Pharmaceutical Expo (INTERPHEX) exhibit in the Jacob K. Javits Convention Center, April 17-19, booth 3544. The... Read more

Agilent Announces Departure of Patrick Kaltenbach

Agilent Announces Departure of Patrick Kaltenbach SANTA CLARA, Calif., April 16, 2018 Agilent Technologies Inc. (NYSE: A) today announced that Patrick Kaltenbach, senior vice president, Agilent and president, Life Sciences and Analytical Group (LSAG), will leave the company on April 20, 2018. A replacement process for Kaltenbach’s position is underway, drawing on Agilent’s deep internal... Read more

Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline

Basel, 16 April 2018 Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline Breadth of data will reinforce efficacy and safety of OCREVUS in relapsing and primary progressive multiple sclerosis and demonstrate its benefits in slowing disability progression, including new cognitive and biomarker results Important research in Alzheimer’s... Read more

Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline

Basel, 16 April 2018 Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline Breadth of data will reinforce efficacy and safety of OCREVUS in relapsing and primary progressive multiple sclerosis and demonstrate its benefits in slowing disability progression, including new cognitive and biomarker results Important research in Alzheimer’s... Read more